Skip to main content

6 July 2025

Last updated: Saturday 5 July 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Symphogen sees opportunities in antibody mixtures

Tuesday 22 March 2011

Interviewee/Contributor

Kirsten Drejer

Organisation

Symphogen A/S

Organisations

GfK Bridgehead
European Confederation of Pharmaceutical Entrepreneurs
Nextech Venture AG
University of Nottingham and Nottingham University NHS Trust
European Commission
Novo Holdings A/S
Shore Capital
Ariceum Therapeutics GmbH
Merck Sharp & Dohme (Europe)
VIB

Interviewees and Contributers

Marc Rogers
Simon Chandler
Ilka Wicke
Jan Fagerberg
Iain McGill
Patrick Verheyen
Ed Corbett
Alexander Gebauer
Frank Schnieders
Gerben Moolhuizen and Kees Melief

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Louise Peacock joins Aravax

Saturday 5 July 2025

Hans Menssen joins Priothera

Saturday 5 July 2025

Filippa Stenberg joins Mölnlycke Health Care

Saturday 5 July 2025

Commit Biologics appoints scientific advisory board

Saturday 5 July 2025

Cristina Csimma joins Asgard Therapeutics

Saturday 5 July 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form